Prostatic Obstruction Investigation Team Multicenter Study

NCT03394651 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 11500

Last updated 2018-11-14

No results posted yet for this study

Summary

The present is a multicenter, observational study organized by the Prostatic Obstruction Investigation Team (POInT), with a main purpose of looking into the current status and symptom progression of male lower urinary tract symptoms patients in China.

Conditions

  • Lower Urinary Tract Symptoms

Interventions

DRUG

Oral medications to treat lower urinary tract symptoms

Patients in this group will receive oral medication(s) depending on doctors' prescriptions.

PROCEDURE

Minimal invasive transurethral prostate procedures

Patients in this group will receive surgical treatment.

Sponsors & Collaborators

  • Beijing Hospital

    collaborator OTHER_GOV
  • Zhongda Hospital

    collaborator OTHER
  • RenJi Hospital

    collaborator OTHER
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    collaborator OTHER
  • The Second Hospital of Nanjing Medical University

    collaborator OTHER
  • Shanghai Changzheng Hospital

    collaborator OTHER
  • Third Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • First Affiliated Hospital of Suzhou Medical College

    collaborator OTHER
  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Zhujiang Hospital

    collaborator OTHER
  • Zhejiang University

    collaborator OTHER
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Xinqiao Hospital of Chongqing

    collaborator OTHER
  • Zhejiang Provincial People's Hospital

    collaborator OTHER
  • Huashan Hospital

    collaborator OTHER
  • Southwest Hospital, China

    collaborator OTHER
  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • The First Affiliated Hospital of Beijing University

    collaborator UNKNOWN
  • Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

    collaborator OTHER
  • Tianjin Medical University Second Hospital

    collaborator OTHER
  • The Third Affiliated Hospital of Beijing University

    collaborator UNKNOWN
  • Jiangsu Provincial People's Hospital

    collaborator OTHER
  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Yinghao Sun, MD, PhD · Changhai Hospital

  • Wei Xue, MD, PhD · RenJi Hospital

  • Qi-Xiang Song, MD,PhD · Changhai Hospital

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-04-01
Completion
2022-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03394651 on ClinicalTrials.gov